Access

Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in genomics, we have the obligation to drive down the cost of sequencing, expand access to diagnostics technology, and increase the diversity of genomics data to realize health equity for billions of people around the world.

Videos from this campaign

Stephanie Lheureux, MD, PhD,Princess Margaret Cancer Centre (PMCC).
Illumina Booth at UK Festival of Genomics & Biodata
Text

Content from this campaign

Responsible Business & Employee Engagement

Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million.

Health & Healthcare

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator.

Health & Healthcare

Berry Oncology Utilizes Illumina Technology to Accelerate Early Liver Cancer Detection in China
The CEO of Berry Oncology, a subsidiary of Berry Genomics, is overseeing China’s first and only large-scale, forward-looking cohort study of early liver cancer screening based on next-generation sequencing (NGS) technology.

Health & Healthcare

Providence Molecular Genomics Lab Utilizes Illumina Technology to Offer Genomics for All
In the future, what if you could sequence your cancer patients by the thousands, provide answers quicker, and deliver more effective treatment and better care—on a routine basis? For Providence, the nation’s third largest not-for-profit health system, that future is the present.

Health & Healthcare

Illumina Coordinates Research and Efforts in China’s Rare Disease Community
There are nearly 7,000 types of rare diseases, and about 80 percent of them are caused by genetic mutations. “Compared with common diseases, rare diseases are difficult to diagnose from the very beginning,” says Yiou Wang, Founder of the Illness Challenge Foundation. “Diagnosis is the first step in the patient journey, but it’s a key step to identify the direction.”

Health & Healthcare

Extending COVID Surveillance Capabilities Beyond Big Cities
“Last month, we had the biggest peak [of positive COVID cases] since the pandemic began,” says Dr. Adrian Alejandro Ceballos López, Medical Director of Biomédicos de Mérida.

Health & Healthcare

What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
The COVID-19 pandemic is a hands-on workshop in how genetic information can help us more quickly control a pandemic. Relying on the SARS-CoV-2 code, researchers at academic labs were ready to develop a diagnostic test for the virus within weeks.

Health & Healthcare

The Vaccination of an Entire City in Brazil
Late this spring, life began to roar back in Serrana, a town in southeast Brazil. Friends and neighbors started gathering after a year of isolation. Hair salons and restaurants are seeing more and more visitors.

Innovation & Technology

Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
Every year, 4,400 unidentified bodies are recovered in the US, according to the National Missing and Unidentified Persons System (NamUs). Whether they were victims of a crime or they passed away from other causes, most of these people do not get identified.

Health & Healthcare

Illumina and LetsGetChecked Collaborate on Surveillance Projects to Detect Covid-19 Variants
Illumina logo

More from Illumina

  1. People
    Harnessing the world’s best talent and giving them the opportunity to thrive allows us to make world-changing leaps in human health and beyond. Our...

  2. Access
    Genomics should be available to the many, not the few. It has the power to save lives and vastly improve the human condition. As the leader in...

  3. Business
    At Illumina, the faster we can innovate, the more lives we can help save. As a genomics pioneer, we have proven through focused and continued...

  4. Environment
    We are committed to integrating environmental stewardship into the way we operate. We recognize the importance of the environment in creating a...

  5. Community
    By sharing our time, talent, and technology, we aim to inspire, support, and empower our communities, our employees, and the next generation.

  6. Operating Responsibly
    Our role as a genomics pioneer brings with it the responsibility to enable innovation for good, ensuring that the technology we create and the data we...